Gyre Therapeutics GYRE
NASDAQ GYRE
$7.33 +0.01 (+0.14%)
At close: Sep 30, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Restructuring Costs (2012 - 2015)

Updated

Gyre Therapeutics' Restructuring Costs was $874,000 in Q2 2015, down 24.4% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Restructuring Costs (2012 - 2015) Analysis & Trends

On a trailing twelve-month basis, Gyre Therapeutics' Restructuring Costs was $3.75 million through Jun 30, 2015; for FY2014, it was $318,000, up 3.9% from FY2013.

  • In earlier years, Restructuring Costs was $306,000 in FY2013 (-91.8%) and $3.72 million in FY2012.
  • Quarterly Restructuring Costs has moved between $318,000 (Q4 2014) and $2.31 million (Q2 2012) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Gyre Therapeutics 777.23 Mn 579.94 Mn 26.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 874,000.00
Mar 31, 2015 1.16 Mn
Dec 31, 2014 318,000.00
Dec 31, 2012 1.41 Mn
Jun 30, 2012 2.31 Mn
API Access

Gyre Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=GYRE&period=max&api_key=YOUR_API_KEY